412 related articles for article (PubMed ID: 24621795)
1. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
Kotecha D; Holmes J; Krum H; Altman DG; Manzano L; Cleland JG; Lip GY; Coats AJ; Andersson B; Kirchhof P; von Lueder TG; Wedel H; Rosano G; Shibata MC; Rigby A; Flather MD;
Lancet; 2014 Dec; 384(9961):2235-43. PubMed ID: 25193873
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
[TBL] [Abstract][Full Text] [Related]
4. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
[TBL] [Abstract][Full Text] [Related]
6. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Stankovic I; Neskovic AN; Putnikovic B; Apostolovic S; Lainscak M; Edelmann F; Doehner W; Gelbrich G; Inkrot S; Rau T; Herrmann-Lingen C; Anker SD; Düngen HD
Int J Cardiol; 2012 Nov; 161(3):160-5. PubMed ID: 22726401
[TBL] [Abstract][Full Text] [Related]
7. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
8. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
[TBL] [Abstract][Full Text] [Related]
9. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
Mulder BA; van Veldhuisen DJ; Crijns HJ; Böhm M; Cohen-Solal A; Babalis D; Roughton M; Flather MD; Coats AJ; Van Gelder IC
Eur J Heart Fail; 2012 Oct; 14(10):1171-8. PubMed ID: 22764183
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
[TBL] [Abstract][Full Text] [Related]
11. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
Pratt CM; Singh SN; Al-Khalidi HR; Brum JM; Holroyde MJ; Marcello SR; Schwartz PJ; Camm AJ;
J Am Coll Cardiol; 2004 Apr; 43(7):1211-6. PubMed ID: 15063432
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
[TBL] [Abstract][Full Text] [Related]
14. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
[TBL] [Abstract][Full Text] [Related]
16. Role of beta-blocker therapy in heart failure and atrial fibrillation.
Fung JW; Yu CM; Kum LC; Yip GW; Sanderson JE
Card Electrophysiol Rev; 2003 Sep; 7(3):236-42. PubMed ID: 14739721
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
18. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
Piccini JP; Abraham WT; Dufton C; Carroll IA; Healey JS; van Veldhuisen DJ; Sauer WH; Anand IS; White M; Wilton SB; Aleong R; Rienstra M; Krueger SK; Ayala-Paredes F; Khaykin Y; Merkely B; Miloradović V; Wranicz JK; Ilkhanoff L; Ziegler PD; Davis G; Emery LL; Marshall D; Kao DP; Bristow MR; Connolly SJ;
JACC Heart Fail; 2019 Jul; 7(7):586-598. PubMed ID: 31042551
[TBL] [Abstract][Full Text] [Related]
19. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
20. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.
Nasr IA; Bouzamondo A; Hulot JS; Dubourg O; Le Heuzey JY; Lechat P
Eur Heart J; 2007 Feb; 28(4):457-62. PubMed ID: 17289748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
